News

For compliance specialists across the pharmaceutical and medical device supply chain, the Drug Supply Chain Security Act (DSCSA) has long been viewed as a phased journey. Requirements were introduced incrementally, enforcement timelines shifted, and many organizations...

State licensing requirements continue to evolve across the pharmaceutical and medical device landscape. New rules, updated interpretations, revised application forms, and changing renewal timelines can all affect a company’s ability to operate compliantly. For...

For pharmaceutical manufacturers, wholesale distributors, 3PLs, repackagers, reverse distributors, and medical device companies, state license renewals are often viewed as routine paperwork. A deadline to track. A form to submit. A fee to pay. But in reality, state...

Drug price transparency reporting remains one of the most challenging compliance obligations for pharmaceutical companies. While these requirements have been in place for several years, state legislatures and regulatory agencies continue to refine their expectations,...

The Drug Supply Chain Security Act (DSCSA) has been a focal point for the pharmaceutical industry for years. While much of the early effort centered on systems, data exchange, and stabilization, compliance expectations have clearly shifted. Regulators are no longer...

The pharmaceutical and medical device supply chain looks very different today than it did even a decade ago. What was once a more linear path from manufacturer to distributor has evolved into a highly interconnected network of partners, facilities, and outsourced...

As the pharmaceutical and medical device industries move into 2026, compliance teams are facing a familiar reality with a new level of intensity. Regulatory expectations continue to expand, supply chains are more complex than ever, and state-level compliance...

As the year comes to a close, many pharmaceutical and medical device companies are focused on budgets, forecasts, and strategic planning. Too often state licensing and regulatory compliance is only addressed reactively once renewal notices arrive or issues surface....

Legal teams that advise pharmaceutical and medical device companies are taking on more responsibility each year as regulatory expectations grow across federal, state, and territorial agencies. Whether your firm handles mergers and acquisitions, stock sales, corporate...